Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: James Silverman who wrote (903)	11/6/1997 9:52:00 AM
From: Steve Harmon	Respond to of 2742

Jim, Cash- $15 mil. IL-1- $21 mil. TOTAL-$36 mil. Steve

To: James Silverman who wrote (903)	6/30/1999 2:20:00 PM
From: Walter Morton	Respond to of 2742

Evidence That IL-1ß Mediates Bone Resorption AA Sequence of Natural Osteoclast Activating Factor OAF=IL-1ß IL-1ß induces bone resorption in vitro IL-1ß elevated levels in gingival fluid correlate with severity of bone resorption Osteoporosis in elderly patients is reduced with high spontaneous IL-1Ra production; vice versa Blocking IL-1 receptors reduces spontaneous OAF activity in human myeloma cells Soluble IL-1 receptors prevent OAF activity of conditioned media Anti- IL-1ß antibodies (not anti-IL-1a) reduce Spontaneous OAF activity in human myeloma cells emedtrade.com If you don't have a password, go to genomesecurities.com and click on HERE at the top of the page.